ORMP·68403P203·US·Common Stock·Healthcare - Biotechnology-Activist
ORMP (ORAMED PHARMACEUTICALS INC) is held by 38 institutional investors as of Q1 2026. Largest holders: MERCER GLOBAL ADVISORS INC /ADV ($6.5M), MARSHALL WACE, LLP ($882,677), Rathbones Group PLC ($792,261). Net institutional sentiment: Mixed.
Showing 1-20 of 42
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer